Odesivimab
Odesivimab is a human monoclonal antibody, targeting Ebola virus glycoprotein with a KD value of 7.74 nM for recombinant histidine-tagged Makona strain Ebola virus glycoprotein ectodomain protein. Odesivimab can be used in research of Ebola virus infection[1].
Product Specifications
CAS Number
[2135632-30-1]
Product Name Alternative
REGN-3471
UNSPSC
12352203
Target
Filovirus
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/odesivimab.html
Purity
99.64
Solubility
10 mM in DMSO
Smiles
[Odesivimab]
Molecular Weight
(146.16 kDa)
References & Citations
[1]Markham A. REGN-EB3: First Approval. Drugs. 2021 Jan;81 (1) :175-178.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items